Pfizer, Inc. (PFE) Reports In-Line Q3 EPS; Announces $10B Buyback Plan
Tweet Send to a Friend
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
